Key result
A review of post-PCI patient management emphasizes the importance of secondary prevention through risk factor modification and effective communication between clinicians and cardiologists.
This review emphasizes the importance of managing early post-PCI complications, dual antiplatelet therapy, and secondary prevention through risk factor modification.
Supports risk factor modification and clinician-cardiologist communication post-PCI; leaves open prospective validation of these strategies.
The exponential increase in the numbers of percutaneous coronary interventions (PCIs) has led to many clinicians having to care for post-PCI patients. We review the management of early problems seen in post-PCI patients, such as vascular access site complications, contrast nephropathy, drug-induced thrombocytopaenia and chest pain. The management of possible restenosis and the use of stress testing are discussed. The complications from dual antiplatelet therapy are addressed. The prognosis of the post-PCI patient, the implications of co-existent heart failure and the newer technologies of implantable defibrillator and cardiac resynchronisation therapy are reviewed. We conclude by emphasising the importance of secondary prevention by risk factor modification as well as the communication between the clinician and the cardiologist.
No takes yet. Share an insight, caveat, or question.
Wong et al. (2006) conducted a review in Post-percutaneous coronary intervention (PCI). Management of post-PCI patients was evaluated. A review of post-PCI patient management emphasizes the importance of secondary prevention through risk factor modification and effective communication between clinicians and cardiologists.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: